StockData
AstraZeneca PLC logo

AstraZeneca PLC

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca Other Oncology medicines by Quarter

Other Oncology medicines — Worldwide product sales ($M) ($M)

QuarterlyAnnual

AstraZeneca Other Oncology medicines: $102M in Q2 2026, down 3.8% from a year earlier.

Latest, Q2 2026
102
Period ended Jun 30, 2026
Change on a year earlier
-3.8%
106 in Q2 2025
History
42 quarters
Since Q1 2016
Sources
27
Documents cited below

Where the Q2 2026 figure comes from

“|| Other Oncology | 102 | | ( 4 ) | | ( 5 ) | | 2 | | 58 | | 69 | | ( 2 ) | | ( 5 ) | | 4 | | ( 15 ) | | ( 28 ) | | 27 | | ( 11 ) | | ( 3 )”

Source: Form 6-K FY2026Q2 Earnings Release ↗

Reported in Form 6-K Quarterly & Form 20-F Product Sales by Medicine & Region Tables.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOther Oncology medicines — Worldwide product sales ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026102-3.8%Form 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 2026101-8.2%Form 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 2025103+6.2%Form 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 20251060.0%Form 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 2025106-2.8%Form 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 2025110+2.8%Form 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 202497+94.0%Form 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 2024106+96.3%Form 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 2024109+101.9%Form 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 2024107+62.1%Form 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 202350+400.0%Form 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 202354+440.0%Form 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 202354+350.0%Form 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 202366+450.0%Form 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 202210-23.1%Form 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 202210-23.1%Form 6-K FY2022Q3 Earnings Release ↗

Breakdown

What makes up other Oncology medicines

Cite this data

StockData. (2026). AstraZeneca Other Oncology medicines ($M), quarterly Q1 2016–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-other-oncology-world

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.